Cargando…

Antiretroviral Drug Resistance Mutations among HIV Treatment Failure Patients in Tehran, Iran

BACKGROUND: This study aimed to determine drug resistance mutations in patients with virological failure and find correlation between HIV drug resistance test and viral load. METHODS: Blood sample was collected from 51 patients who suspicious treatment failure in the center of Imam Khomeini Hospital...

Descripción completa

Detalles Bibliográficos
Autores principales: FARROKHI, Molood, MOALLEMI, Samaneh, SHIRKOOHI, Reza, GOLMOHAMMADI, Reza, AHSANI-NASAB, Sara, SARDASHTI, Sara, ABBASIAN, Ladan, BAESI, Kazem, MOHRAZ, Minoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632328/
https://www.ncbi.nlm.nih.gov/pubmed/29026792
_version_ 1783269680451944448
author FARROKHI, Molood
MOALLEMI, Samaneh
SHIRKOOHI, Reza
GOLMOHAMMADI, Reza
AHSANI-NASAB, Sara
SARDASHTI, Sara
ABBASIAN, Ladan
BAESI, Kazem
MOHRAZ, Minoo
author_facet FARROKHI, Molood
MOALLEMI, Samaneh
SHIRKOOHI, Reza
GOLMOHAMMADI, Reza
AHSANI-NASAB, Sara
SARDASHTI, Sara
ABBASIAN, Ladan
BAESI, Kazem
MOHRAZ, Minoo
author_sort FARROKHI, Molood
collection PubMed
description BACKGROUND: This study aimed to determine drug resistance mutations in patients with virological failure and find correlation between HIV drug resistance test and viral load. METHODS: Blood sample was collected from 51 patients who suspicious treatment failure in the center of Imam Khomeini Hospital, Tehran, Iran in 2015. Viral voluntary counseling and testing load test was done and the patients with viral load above 1000 copies choose for detection of drug resistance mutations by genotyping method (29 patients). RESULTS: The majority of patients (82.75) harbored the HIV subtype CRF 35 A-D. The 86.2% patients compromised at least one resistance mutation. The analysis of reverse transcriptase showed M184V (68.9%), T215YISF (44.8%), K103N (27.6%) and the analysis results of protease revealed G73SC (13.8%) and I47VA (6.9%). Eventually, the significant correlation between viral load and drug resistance was found. CONCLUSION: The result of our research stress the significance of recognizing drug resistant on time that prohibits the accumulation of drug resistance mutation and circulates the resistance strain of HIV-1 virus and the importance of national study according to the reliable findings for treatment guidelines.
format Online
Article
Text
id pubmed-5632328
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Tehran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-56323282017-10-12 Antiretroviral Drug Resistance Mutations among HIV Treatment Failure Patients in Tehran, Iran FARROKHI, Molood MOALLEMI, Samaneh SHIRKOOHI, Reza GOLMOHAMMADI, Reza AHSANI-NASAB, Sara SARDASHTI, Sara ABBASIAN, Ladan BAESI, Kazem MOHRAZ, Minoo Iran J Public Health Original Article BACKGROUND: This study aimed to determine drug resistance mutations in patients with virological failure and find correlation between HIV drug resistance test and viral load. METHODS: Blood sample was collected from 51 patients who suspicious treatment failure in the center of Imam Khomeini Hospital, Tehran, Iran in 2015. Viral voluntary counseling and testing load test was done and the patients with viral load above 1000 copies choose for detection of drug resistance mutations by genotyping method (29 patients). RESULTS: The majority of patients (82.75) harbored the HIV subtype CRF 35 A-D. The 86.2% patients compromised at least one resistance mutation. The analysis of reverse transcriptase showed M184V (68.9%), T215YISF (44.8%), K103N (27.6%) and the analysis results of protease revealed G73SC (13.8%) and I47VA (6.9%). Eventually, the significant correlation between viral load and drug resistance was found. CONCLUSION: The result of our research stress the significance of recognizing drug resistant on time that prohibits the accumulation of drug resistance mutation and circulates the resistance strain of HIV-1 virus and the importance of national study according to the reliable findings for treatment guidelines. Tehran University of Medical Sciences 2017-09 /pmc/articles/PMC5632328/ /pubmed/29026792 Text en Copyright© Iranian Public Health Association & Tehran University of Medical Sciences http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
FARROKHI, Molood
MOALLEMI, Samaneh
SHIRKOOHI, Reza
GOLMOHAMMADI, Reza
AHSANI-NASAB, Sara
SARDASHTI, Sara
ABBASIAN, Ladan
BAESI, Kazem
MOHRAZ, Minoo
Antiretroviral Drug Resistance Mutations among HIV Treatment Failure Patients in Tehran, Iran
title Antiretroviral Drug Resistance Mutations among HIV Treatment Failure Patients in Tehran, Iran
title_full Antiretroviral Drug Resistance Mutations among HIV Treatment Failure Patients in Tehran, Iran
title_fullStr Antiretroviral Drug Resistance Mutations among HIV Treatment Failure Patients in Tehran, Iran
title_full_unstemmed Antiretroviral Drug Resistance Mutations among HIV Treatment Failure Patients in Tehran, Iran
title_short Antiretroviral Drug Resistance Mutations among HIV Treatment Failure Patients in Tehran, Iran
title_sort antiretroviral drug resistance mutations among hiv treatment failure patients in tehran, iran
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632328/
https://www.ncbi.nlm.nih.gov/pubmed/29026792
work_keys_str_mv AT farrokhimolood antiretroviraldrugresistancemutationsamonghivtreatmentfailurepatientsintehraniran
AT moallemisamaneh antiretroviraldrugresistancemutationsamonghivtreatmentfailurepatientsintehraniran
AT shirkoohireza antiretroviraldrugresistancemutationsamonghivtreatmentfailurepatientsintehraniran
AT golmohammadireza antiretroviraldrugresistancemutationsamonghivtreatmentfailurepatientsintehraniran
AT ahsaninasabsara antiretroviraldrugresistancemutationsamonghivtreatmentfailurepatientsintehraniran
AT sardashtisara antiretroviraldrugresistancemutationsamonghivtreatmentfailurepatientsintehraniran
AT abbasianladan antiretroviraldrugresistancemutationsamonghivtreatmentfailurepatientsintehraniran
AT baesikazem antiretroviraldrugresistancemutationsamonghivtreatmentfailurepatientsintehraniran
AT mohrazminoo antiretroviraldrugresistancemutationsamonghivtreatmentfailurepatientsintehraniran